Last reviewed · How we verify
NCT07204678: REAL-PRECISE
PMCF Study of Precise Pro Rx for Carotid Artery Disease
trial testing PRECISE PRO Rx Nitinol Stent System in Carotid Artery Stenosis in 199 participants. Completed in 27 February 2026.
27 February 2026
Quick facts
| Lead sponsor | Cordis US Corp. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 199 |
| Start date | 30 October 2025 |
| Primary completion | 27 February 2026 |
| Estimated completion | 27 February 2026 |
| Sites | 4 locations across Austria, France, Italy |
Drugs / interventions tested
- PRECISE PRO Rx Nitinol Stent System
Conditions studied
- Carotid Artery Stenosis — all drugs for Carotid Artery Stenosis →
Sponsor
Cordis US Corp. — full company profile →
Who can join
18 and older, any sex, with Carotid Artery Stenosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate long-term clinical safety and performance of the PRECISE PRO RX Nitinol Stent System to treat stenotic lesions of the carotid arteries.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07204678
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Carotid Artery Stenosis
Currently open trials in the same condition.
- NCT07370246 — CAS for Stenosis With High-risk Features for CEA · NA · recruiting
- NCT07247864 — Balloon Guide Catheter Combined With Filter Protection for Carotid Artery Stenting · NA · recruiting
- NCT06924593 — Study on the Trans-Carotid Artery Occlusion Shunt System · NA · recruiting
- NCT07034157 — A Real-World Study on Ultrasound-Based Screening and Integrated Therapeutic Strategies for Patients With Concomitant Cor · recruiting
- NCT06936176 — Prospective Trial of IVL for Calcified Carotid Lesions(CREATE Trial) · NA · recruiting
Other Cordis US Corp. trials
Trials by the same sponsor.
- NCT07338890 — Post-Market Clinical Follow-Up of S.M.A.R.T. Family of Stents in Treating Iliac and Femoropopliteal Artery Disease · not yet recruiting
- NCT05554471 — Evaluation of Safety and Efficacy of the Mynx Control Venous Vascular Closure Device 6F-12F vs Manual Compression · NA · completed
- NCT05399680 — Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femorop · NA · completed
- NCT05312580 — PMCF Study for Peripheral Arteries Above the Knee (ATK) · completed
- NCT05543096 — PMCF Study for Cardiology Access Procedures · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07204678 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cordis US Corp.
- Last refreshed: 13 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07204678.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing